Company Overview of Merck Serono S.A.
Merck Serono S.A., a biopharmaceutical company, discovers, develops, manufactures, and markets prescription medicines of chemical and biological origins. The company develops treatments to manage neurodegenerative diseases, such as multiple sclerosis; oncology therapies to treat colorectal, and head and neck cancer; and a portfolio of fertility drugs for every stage of the reproductive cycle and recombinant versions of various hormones needed to treat infertility. It also provides specialized therapies for patients with selected endocrine and metabolic disorders, such as hyperphenylalaninemia and phenylketonuria, childhood growth hormone and adult growth hormone deficiency, HIV-associated wa...
9, chemin des Mines
Case postale 54
Founded in 2007
Key Executives for Merck Serono S.A.
Chief Executive Officer and President
Head of Global Business Unit Allergy and Chief Executive Officer of Allergopharma
Chief Executive Officer of Consumer Health Division and President of Consumer Health Division
Chief Intellectual Property Counsel
Compensation as of Fiscal Year 2013.
Merck Serono S.A. Key Developments
Merck Serono S.A. Reports Sales Results for the Year Ended December 31, 2013
Mar 6 14
Merck Serono S.A. reported sales results for the year ended December 31, 2013. For the year, despite solid organic growth of 3.9%, the company's sales declined by 0.7% to €5.95 billion compared to €6 billion a year ago.
Merck Serono Appoints Steven Hildemann as Global Chief Medical Officer
Jan 13 14
Merck Serono announced the appointment of Steven Hildemann, MD, PhD, as Global Chief Medical Officer (CMO) and Head of Global Medical and Safety for the Merck Serono division. Dr. Hildemann is a board-certified Internist and Cardiologist trained in the U.S. and Germany. In his role as CMO, Hildemann will be based in Darmstadt, Germany, and report to the Global Head of Research & Development of Merck Serono, Dr. Annalisa Jenkins. As CMO, Hildemann will be responsible for Global Medical Affairs, Global Drug Safety and External Scientific Affairs for Merck Serono. In this capacity, one of his primary responsibilities will be to support the safe and appropriate use of and access to Merck Serono medicines. He will also serve as a member of the R&D Executive Leadership Team.
Merck Serono Presents at Biotech Showcase 2014, Jan-15-2014 08:00 AM
Dec 22 13
Merck Serono Presents at Biotech Showcase 2014, Jan-15-2014 08:00 AM. Venue: Parc 55 Wyndham Union Square Hotel, San Francisco, California, United States. Speakers: Jasper Bos, Director, Merck Serono Ventures.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|